GWA Study in Patients With Inflammatory Bowel Disease
Observational · No treatment assigned · 1 site · Chinese University of Hong Kong
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Crohn's Disease and Ulcerative Colitis. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- Age 18 or above
- Informed consent given by patient or family
- Case group (IBD patients) Diagnosis of Crohn's disease or ulcerative colitis defined by endoscopy, radiology and histology
Plus 1 more requirement(s). There are also 2 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 3600 participants are expected to take part.
- Start date: 2010-04.
- Main results expected around 2037-04 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Hong Kong.
Main thing being measured
- To identify genetic variation among three study groups (2 years)
In the researchers’ words
The aim of this study is to identify new genes in Chinese patients that help investigators to understand the biological pathway and functions in a population in whom the incidence of Inflammatory Bowel Disease (IBD) is increasing. And to explore the genetic variations in Chinese patients with IBD.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Crohn's Disease; Ulcerative Colitis |
| Lead sponsor | Chinese University of Hong Kong |
| Enrollment | 3600 (estimated) |
| Start date | 2010-04 |
| Primary completion (est.) | 2037-04 |
| First posted | 2010-06-10 |
| Last updated | 2023-02-08 |
| Official title | Genome Wide Association (GWA) Study in Chinese Patients With Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT01140789 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Age 18 or above * Informed consent given by patient or family Case group (IBD patients) Diagnosis of Crohn's disease or ulcerative colitis defined by endoscopy, radiology and histology Control group (non-IBD cases) Ethically, sex and aged-matched controls attending clinics or endoscopy for functional upper gastrointestinal diseases or screening colonoscopy. Exclusion Criteria: * No consent * Controls will be excluded if they have previously been diagnosed with IBD or if they have a first or second degree relative with IBD.
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Prince of Wales Hospital | Hong Kong | Hong Kong | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.